Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Crynant Mother on £83.30 Allowance Says She Can't Afford Breakfast
Michelle Rees, a 45‑year‑old mother in Crynant, Wales, left her job to look after her 23‑year‑old daughter with severe epilepsy and now survives on a £83.30 (≈$104) weekly carer's allowance that doesn’t cover breakfast. Her story highlights systemic gaps for unpaid carers as a Senedd report shows over 300,000 Welsh carers receive little support.
Homoharringtonine Extends Mouse Lifespan and Cuts Obesity in New Preclinical Study
A team led by Kim et al. reported that homoharringtonine (HHT) acts as a senolytic, extending lifespan and reversing diet‑induced obesity in mice. The findings, published in Nature Communications, suggest a repurposed cancer drug could become a cornerstone of longevity...
Why ICHRA Is No Longer a Fringe Option
Individual Coverage Health Reimbursement Arrangements (ICHRA) are shedding their niche label as large enterprises adopt them to tackle soaring health‑care costs, fragmented workforces, and employee demand for personalized benefits. By converting open‑ended premiums into a fixed employer contribution, ICHRAs give...
Abbisko Therapeutics Secures EMA Orphan‑Drug Designation for FGFR4 Inhibitor Irpagratinib
Abbisko Therapeutics announced that the European Medicines Agency granted orphan‑drug designation to its oral FGFR4 inhibitor irpagratinib for hepatocellular carcinoma. The milestone adds to earlier U.S. designations and comes as the company also secures FDA IND clearance for its FGFR2/3...
Bedrock Bioscience Unveils Gazelle™ Chair, a Non‑Invasive Pelvic‑Floor Therapy Device
Bedrock Bioscience introduced the Gazelle™ Chair, a magnetic‑based, non‑invasive device that strengthens pelvic‑floor muscles in 20‑minute sessions. The chair, now offered through select providers across the U.S., targets bladder leakage, urgency and post‑childbirth weakness, promising a drug‑free alternative for millions...
Atraumatic Joint Pain: 5 Surgeon Tips You Need
Having been an orthopedic surgeon for 30 years...5 things I wish someone had told you before you walked into my office — in atraumatic joint and tendon pain. Most of you will present with atraumatic joint and tendon pain... traumatic injuries...
RenovoRx FY25 Net Loss Expands to $11.2M as CFO Prepares for Mid‑2026 Phase III Enrollment
RenovoRx announced a widened FY25 net loss of $11.2 million, up from $8.8 million a year earlier, while posting its first full year of revenue from the FDA‑cleared RenovoCath device. The company also said it expects to complete enrollment for its Phase III...
NHS to Offer Wegovy to Over 1 Million Heart Patients to Cut Cardiovascular Risk
The NHS has secured a cost‑effective deal with Novo Nordisk to make the GLP‑1 drug Wegovy available to over 1 million English adults who have suffered a heart attack, stroke or peripheral arterial disease and have a BMI of 27 or...
Pharmacierge Partners with Tatler to Recognise UK’s Leading Private Doctors
Pharmacierge, the UK’s leading private e‑prescription and medication delivery platform, has partnered with luxury magazine Tatler to launch the annual Tatler Doctors Guide, highlighting the nation’s top private clinicians. The guide, compiled with input from more than 45 private GPs...
Spectrum Spine's BioBraille Earns FDA Clearance, First Nanotech‑enabled Orthopedic Implant
Spectrum Spine Inc announced that its BioBraille™ surface technology has received FDA clearance, making it the first orthopedic implant to be designated as a nanotechnology device. The clearance covers an anterior cervical cage and paves the way for a broader...
The Digital Imperative: Why the Future of Surgery Will Be Built on Integrated Intelligence, Not More Devices
Surgeons are overwhelmed by isolated devices that generate data without context, creating a hidden cognitive burden in the operating room. The industry is shifting from a hardware‑centric model to integrated platforms that synthesize information in real time, mirroring aviation’s move...
Do Water Picks Really Work? Dentists Weigh In.
Water flossers, also known as oral irrigators, have become a common fixture in American bathrooms since their commercial debut in the 1960s. Dental experts, including UCSF’s Dr. Diana Nguyen, endorse them as a useful adjunct for patients who struggle with...
Pfizer Shares Edge Higher on Strong Oncology Data Amid Flat 2026 Revenue Guidance
Pfizer's shares rose about 0.7% to $27.97 after the company reported positive Phase 3 data for its Talzenna‑Xtandi combo in metastatic prostate cancer and encouraging mid‑stage breast cancer results. The gains came despite a 2026 revenue outlook that is essentially...
Why Standardized Medical Exams Filter for Compliant Workers
The article argues that high‑stakes medical exams—from the GRE and MCAT to the USMLE and Maintenance of Certification—function primarily as filters for compliance rather than tools for developing clinical reasoning. By presenting closed‑system problems with fixed constants, these tests train...
Merck to Acquire Terns Pharmaceuticals for $6.7 B, Accelerating M&A Ahead of Keytruda Patent Expiry
Merck announced a definitive agreement to buy California‑based cancer biotech Terns Pharmaceuticals for an estimated equity value of $6.7 billion. The deal, slated to close in Q2 2026, expands Merck’s hematology pipeline and underscores a rapid M&A cadence designed to cushion the...
Video Wednesday
The April 1, 2026 "Video Wednesday" post serves as a launchpad for a weekly video series that highlights cutting‑edge medical robotics and pandemic‑response technologies. It references earlier "Flickstop" entries that showcased robotic surgery and COVID‑19 disinfection robots, providing visual context for readers....
Prostate Enlargement in Men Over 40: When Surgery Becomes Necessary
Benign prostatic hyperplasia (BPH) affects nearly half of men over 50 and up to 90% of those over 80, causing urinary urgency, weak flow, and nocturia that erode quality of life. While lifestyle changes and alpha‑blockers can manage mild cases,...
ACC 2026: Dulaglutide Promotes Coronary Plaque Stabilisation in Patients with T2D
At the American College of Cardiology 2026 meeting, researchers reported that dulaglutide, a weekly GLP‑1 receptor agonist, stabilised coronary plaques in patients with type‑2 diabetes. In a prospective randomised trial of 39 participants with intermediate coronary stenoses, dulaglutide led to...
Scientists Are Working on “Everything Vaccines”
Vaccines prove their worth when they fail, as recent flu and COVID‑19 seasons have shown. The COVID‑19 pandemic exposed how quickly a novel virus can outpace vaccine development, while the 2025 flu season suffered a mismatch when the H 3 N 2 strain...
Metabolically Healthy Obese Children Still Develop Diabetes
As a medical school professor, I've seen textbooks call it "metabolically healthy obesity." A new study proves that label is dangerously misleading. Karolinska Institute tracked 7,275 children with obesity until age 30. The results in JAMA Pediatrics are staggering: -> 9% of "metabolically...
Rare Disease Advocacy Group Urges Trump Administration to Restore FDA Clarity
A coalition of nearly 100 rare‑disease patient groups, biotech executives and investors wrote to President Trump, Health Secretary Robert F. Kennedy Jr., Medicare administrator Mehmet Oz and FDA Commissioner Marty Makary urging the administration to restore regulatory clarity at the...
Shift From Disease Treatment to Building Durable Health
When 'Normal Labs' Are Unhealthy We sit down with Dr Sandeep Palakodeti —an Ivy League–trained internist who left elite institutions—to unpack why so much of healthcare reacts to disease instead of building durable health, and how treating your body like your...
Smart Drugs Are Here
A recent proof‑of‑concept study introduces DNA‑drug conjugates (DDCs) that turn “smart drugs” into programmable therapies. DDCs use split DNA strands as logic gates to release payloads only when specific biomarker combinations are present, offering higher specificity than antibody‑drug conjugates (ADCs)....
Association Between Prognostic Nutritional Index and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation Combined with Heart Failure with...
A retrospective cohort of 734 patients with atrial fibrillation and heart failure with preserved ejection fraction found that a higher prognostic nutritional index (PNI) was independently associated with lower rates of major adverse cardiovascular events (MACE) and all‑cause mortality over...
Prevalence of Borderline Elevated and Elevated Cholesterol Among New Adult Patients From 23 Hospitals in 12 Cities of Jiangsu Province:...
A multicenter cross‑sectional study of 4,503 newly admitted adult patients across 23 hospitals in Jiangsu Province found that 24.9% had borderline‑elevated or elevated total cholesterol. Prevalence was higher in women (28.7%) than men (22.1%) and peaked at 31.6% among those...
Hospitals Account For Much Greater Share Of Healthcare Costs Than Rx Drugs
Hospital spending drives U.S. health‑care cost growth, accounting for roughly one‑third of total expenditures and 41 % of the increase between 2022 and 2024. Prices for hospital services have surged about 250 % since 2000, outpacing inflation and other sectors such as...
IO Shuts Down Following Regulatory Roadblocks
Danish biotech IO Biotech announced it will wind down operations and file for Chapter 7 bankruptcy after regulatory setbacks. The FDA rejected its biologics license application for the cancer vaccine Cylembio in September, citing insufficient data. A Phase 3 trial combining Cylembio...
Expert Panel Updating NCHPC’s Palliative Care Clinical Practice Guidelines
The National Coalition for Hospice and Palliative Care (NCHPC) has appointed a 33‑member expert panel to draft the fifth edition of its Clinical Practice Guidelines for Quality Palliative Care. First released in 2004, the guidelines set national, evidence‑based standards across...
Some 2027 ACA Exchange Plans Could Ditch Provider Networks
The Centers for Medicare & Medicaid Services (CMS) has drafted rules that would allow non‑network, indemnity‑style health plans to be classified as major medical coverage on the 2027 ACA exchanges. If approved, these plans could qualify for premium tax credits,...
Metformin Undermines Exercise’s Insulin‑Sensitivity Gains
As a medical school professor, I've recommended metformin to countless patients. But a new double-blind trial just revealed something alarming. Metformin BLUNTED the insulin-sensitizing benefits of exercise in adults at risk for metabolic syndrome. The findings from a 16-week RCT: -> Exercise +...
Structured Exercise Boosts Recovery After Colon Cancer Chemotherapy
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer | New England Journal of Medicine https://t.co/Q2DtXIX8vI #exercise #cancer #lifestylemedicine #health #exerciseismedicine
The Dutch Protocol Re-Examined
The Amsterdam University Medical Centre, long regarded as the gold standard for paediatric gender medicine, released a retrospective analysis of 1,470 adolescents referred between 2009 and 2019. The study found that 18% of these youths did not pursue gender‑affirming medical...
How Hospices Can Work with ‘Payviders’
Payviders—insurers that also own provider assets—are reshaping hospice partnerships, with Humana, UnitedHealth and emerging player SCAN Group leading the trend. These entities integrate Medicare Advantage plans, home‑care subsidiaries and primary‑care clinics to create vertically aligned networks. Hospices must adapt to...
Worlds Behind Words 10: LGBTQ Identity, Internalized Stigma, and Gender-Affirming Care
In a recent interview, licensed clinical social worker William Dempsey discusses the surge in LGBTQ self‑identification, now estimated at 9.3% of U.S. adults, and attributes it to generational change, internet‑driven language, and greater mental‑health access. He explains how internalized stigma...
The Strategic Advantage of Automation in Medical Device Manufacturing
Medical device makers face rising production demands, labor shortages, and tighter regulatory scrutiny, turning automation from a tactical upgrade into a strategic imperative. Integrion Automation argues that automation must be embedded in an integrated operational strategy that delivers repeatable precision,...
Medical Podcasts
Medical Design Briefs released a series of podcasts on April 1 2026 highlighting emerging trends in drug delivery. The episodes cover AI‑driven personalized medicine in oncology, sustainability challenges for insulin pens and other devices, intra‑arterial platforms that target solid tumors, and wearable...
Novel Sensor Offers Continuous Blood Leakage Monitoring
Researchers at Hanyang University have developed an ultrathin, flexible, wireless sensor that can be integrated directly onto endovascular stent grafts to continuously monitor for Type‑I endoleaks after abdominal aortic aneurysm repair. The sensor survives catheter crimping, remains biocompatible, and transmits...
Medical Podcasts
Medical Design Briefs released a series of April 2026 podcasts spotlighting emerging drug‑delivery trends. Episodes feature First Ascent Biomedical’s AI‑driven platform that personalizes oncology therapy, MGS engineers discussing greener insulin‑pen designs, RenovoRx’s intra‑arterial delivery system that targets solid tumors, and...
From the Editor: Industrial Mastery Comes to Additive Manufacturing
The Wohlers Report 2026 declares additive manufacturing has entered an "Era of Industrial Mastery," as hardware sales plateau and firms shift focus to utilization. High‑interest rates are tightening capital discipline, prompting medical device companies to extract more value from existing...
Clinical Trial For Brain Cancer Treatment Has Promising Results
A novel glioblastoma treatment combining oral 5‑ALA with low‑intensity ultrasound has shown promising early results, extending median survival by over 14 months in a phase 1 trial for recurrent patients. The approach sensitizes tumor cells to ultrasound, allowing diffuse targeting of...
‘Cracks Show’ as CDRH Staff Contend with Heavy Workloads
One year after the Trump administration’s sweeping HHS layoffs, the FDA’s Center for Devices and Radiological Health (CDRH) is grappling with severe understaffing and morale issues. Between September 2024 and January 2026 the agency shed roughly 21 % of its workforce—over 4,400 employees—leaving...
Sweat-Powered Sticker Turns Drinking Cup Into a Health Sensor
UC San Diego engineers have created a battery‑free electronic sticker that attaches to drinking cups and measures a user’s vitamin C levels from fingertip sweat. The biofuel cell harvests sweat‑derived electricity to power a hydrogel‑based sensor, which wirelessly sends results to...
FDA, After Turbulent Year, Leaves Drugmakers Guessing on Its Direction
The FDA’s leadership turmoil has intensified under Commissioner Marty Makary, with the agency cycling through multiple heads of its CDER and CBER centers in just over a year. Public‑facing comments from senior officials have sparked sharp stock moves, most notably...
AI-Generated Sensors Open New Paths for Early Cancer Detection
MIT and Microsoft researchers unveiled CleaveNet, an AI system that designs peptide sensors targeting cancer‑linked proteases. The model rapidly generates highly specific sequences, cutting the design time from months to minutes and slashing experimental costs. Coated nanoparticles release cleaved peptides...
Engineers Create Hydrogels to Monitor Activity in the Body
Engineers at Washington University in St. Louis have developed granular bioelectronic hydrogels composed of PEDOT:PSS microparticles that can be injected, 3D‑printed, or spread over tissue. The material behaves like a liquid under force but solidifies into a porous, paste‑like matrix,...
Designing Continuous Glucose Monitors for Safety, Reliability, and Patient Comfort
Continuous glucose monitors (CGMs) have become essential for diabetes care, delivering real‑time glucose data and reducing the need for finger‑stick tests. Engineers face the challenge of creating ultra‑low‑power, miniature devices that remain reliable and safe for 7‑14 days on a...
Sensor Technology Detects Life-Threatening Complications After Intestinal Surgery
Researchers at TU Dresden and Rostock University Hospital have created a fully absorbable, implantable sensor film that can be sewn into intestinal anastomoses during surgery. The device continuously measures tissue impedance and temperature, delivering real‑time alerts when circulatory disorders emerge....
Will Pfizer’s Lyme Disease Gamble Pay Off or Set the Space Back?
Pfizer and French partner Valneva are seeking FDA approval for a 6‑valent OspA Lyme disease vaccine after a late‑stage trial showed more than 70% efficacy, though the study missed its primary statistical endpoint due to low infection rates. The candidate...
How Drug Discovery Is Tackling Global Health Challenges
In this DDW podcast episode, host Bruno Quinney discusses two recent DDW articles: one on the urgent need to combat antimicrobial resistance (AMR) with insights from Professor Janet Hemingway, and another on the rapid expansion of mRNA therapeutics. Hemingway highlights...
Pa. Air Medical Pilot Reaches 3,000 Patient Transports Milestone
Mike Moore, JeffSTAT lead pilot for Air Methods, completed his 3,000th patient transport in March, a milestone reached by few air‑medical pilots. The achievement caps an 18‑year tenure at the Lansdale base and reflects over 7,750 total flight hours, including...